IP Library Granted Patent US 7,125,517
Granted Patent B2
US 7,125,517 · App. 10/914,492 · Granted Oct 24, 2006

Systems and methods for detection of analytes in biological fluids

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,125,517
App. No.
10/914,492
Granted
Oct 24, 2006
Kind
B2
Abstract

The invention provides a heterogeneous immunoassay for detection of antibodies and antigens based on specific antigen-antibody immune complex formation with multiple antigen-bearing conjugate components. The invention further provides means for optimizing the assay format for the detection of both low and high-affinity antibodies, and provides means for quantitative detection of both antibody and the corresponding antigen present in a sample.

Claims (19)

1. A kit comprising

a first component comprising biotin linked, through a polyethylene glycol spacer, to albumin,

a second component comprising a biotin-binding moiety conjugated to an antigen or hapten that binds an antimicrobial antibody to be detected in a sample, and

a third component comprising the antigen or hapten conjugated to a label.

2. The kit of claim 1 , wherein the second and third components are supplied as dry samples or liquid samples, wherein the dry or liquid samples may be separate or mixtures of the second and third components.

3. The kit of claim 1 , wherein the second and third components comprise more than one antigen or hapten molecule.

4. The kit of claim 1 , wherein the second component and the third component each comprise two or more different antigens or haptens that are chemically linked to the biotin-binding moiety or the detector label, respectively.

5. The kit of claim 1 , wherein the biotin-binding moiety is avidin or streptavidin.

6. The kit of claim 1 , wherein the sample is taken from a human or animal having a microbial infection.

7. The kit claim 6 , wherein the microbial infection is Lyme disease.

8. The kit of claim 1 , wherein the antigen is C6 peptide derived from VLSe protein of B. burgdorferi.

9. The kit of claim 1 , wherein the antigen is C10 peptide derived from OspC protein of B. burgdorferi.

10. The kit of claim 1 , wherein the antigens are peptides derived from VLSe protein (C6) and OspC protein (C10) of B. burgdorferi.

11. The kit of claim 1 , further comprising instructions for practicing the method of detecting an antibody in a sample.

12. A kit comprising

a solid support to which is noncovalently adsorbed a first component comprising biotin linked, through a polyethylene glycol spacer, to albumin;

a second component comprising a biotin-binding moiety conjugated to an antigen or hapten that binds an antimicrobial antibody to be detected in a sample; and

a third component comprising the antigen or hapten conjugated to a label.

13. A kit of claim 12 wherein the second and third components are present in a single reagent mixture.

Assignments (4)
RELEASE OF SECURITY INTEREST (TERM) Recorded Nov 7, 2018
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: OXFORD IMMUNOTEC, INC.; OXFORD IMMUNOTEC GLOBAL PLC; OXFORD IMMUNOTEC LIMITED; IMMUNETICS, INC.
Reel/Frame 047445/0487 →
RELEASE OF SECURITY INTEREST (REVOLVING) Recorded Nov 7, 2018
From: MIDCAP FUNDING IV TRUST, AS SUCCESSOR TO MIDCAP FINANCIAL TRUST
To: OXFORD IMMUNOTEC, INC.; OXFORD IMMUNOTEC GLOBAL PLC; OXFORD IMMUNOTEC LIMITED; IMMUNETICS, INC.
Reel/Frame 047890/0001 →
SECURITY INTEREST (TERM LOAN) Recorded Nov 3, 2016
From: IMMUNETICS, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 040558/0408 →
SECURITY INTEREST (REVOLVING LOAN) Recorded Nov 3, 2016
From: IMMUNETICS, INC.
To: MIDCAP FUNDING IV TRUST, AS AGENT
Reel/Frame 040558/0445 →